Seegene, Inc.

KOSDAQ:A096530 Stock Report

Market Cap: ₩1.1t

Seegene Future Growth

Future criteria checks 4/6

Seegene is forecast to grow earnings and revenue by 67.3% and 13% per annum respectively. EPS is expected to grow by 67.3% per annum. Return on equity is forecast to be 8.9% in 3 years.

Key information

67.3%

Earnings growth rate

67.32%

EPS growth rate

Biotechs earnings growth44.5%
Revenue growth rate13.0%
Future return on equity8.93%
Analyst coverage

Low

Last updated12 Nov 2025

Recent future growth updates

Recent updates

Seegene (KOSDAQ:096530) Seems To Use Debt Rather Sparingly

Nov 25
Seegene (KOSDAQ:096530) Seems To Use Debt Rather Sparingly

Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?

Jul 24
Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?

Seegene, Inc. (KOSDAQ:096530) Shares Fly 25% But Investors Aren't Buying For Growth

May 13
Seegene, Inc. (KOSDAQ:096530) Shares Fly 25% But Investors Aren't Buying For Growth

Seegene, Inc. (KOSDAQ:096530) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Jan 08
Seegene, Inc. (KOSDAQ:096530) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Investors Shouldn't Be Too Comfortable With Seegene's (KOSDAQ:096530) Earnings

Nov 22
Investors Shouldn't Be Too Comfortable With Seegene's (KOSDAQ:096530) Earnings

Is Seegene (KOSDAQ:096530) Using Too Much Debt?

Nov 12
Is Seegene (KOSDAQ:096530) Using Too Much Debt?

Seegene, Inc.'s (KOSDAQ:096530) Share Price Boosted 44% But Its Business Prospects Need A Lift Too

Aug 10
Seegene, Inc.'s (KOSDAQ:096530) Share Price Boosted 44% But Its Business Prospects Need A Lift Too

A Look At The Fair Value Of Seegene, Inc. (KOSDAQ:096530)

Mar 07
A Look At The Fair Value Of Seegene, Inc. (KOSDAQ:096530)

Is Seegene, Inc. (KOSDAQ:096530) Trading At A 32% Discount?

May 06
Is Seegene, Inc. (KOSDAQ:096530) Trading At A 32% Discount?

I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease

Mar 15
I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease

Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?

Feb 25
Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?

Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?

Feb 08
Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?

What Is The Ownership Structure Like For Seegene, Inc. (KOSDAQ:096530)?

Jan 22
What Is The Ownership Structure Like For Seegene, Inc. (KOSDAQ:096530)?

Earnings and Revenue Growth Forecasts

KOSDAQ:A096530 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027610,900102,16791,750139,7503
12/31/2026537,86774,30073,650117,9503
12/31/2025473,35057,35041,600166,2002
9/30/2025458,942-63966,927109,429N/A
6/30/2025454,222-13,53167,006114,904N/A
3/31/2025440,30210,64177,475124,370N/A
12/31/2024414,252-20,33741,76485,391N/A
9/30/2024399,42229,47268,855106,763N/A
6/30/2024382,48423,12851,92984,168N/A
3/31/2024367,272-3,46143,73674,663N/A
12/31/2023367,37566963,05394,932N/A
9/30/2023389,688-2,57860,26996,806N/A
6/30/2023448,646-8,97138,57780,689N/A
3/31/2023492,15918,71934,18292,771N/A
12/31/2022853,561182,139246,557319,009N/A
9/30/20221,140,776343,230323,190401,561N/A
6/30/20221,295,241447,057496,227579,900N/A
3/31/20221,470,535537,404501,890574,273N/A
12/31/20211,370,833536,559267,913334,024N/A
9/30/20211,402,531559,365307,852377,100N/A
6/30/20211,424,097618,128153,723331,480N/A
3/31/20211,395,194633,289218,235393,526N/A
12/31/20201,125,216502,281207,900383,157N/A
9/30/2020717,254321,43779,846234,884N/A
6/30/2020421,777175,80973,584103,313N/A
3/31/2020176,24555,32410,46731,529N/A
12/31/2019121,95326,67222,35427,141N/A
9/30/2019118,44526,67618,47422,290N/A
6/30/2019110,40223,176N/A21,008N/A
3/31/2019105,86114,304N/A15,670N/A
12/31/2018102,26510,098N/A14,010N/A
9/30/201897,9755,951N/A17,831N/A
6/30/201894,6844,972N/A9,870N/A
3/31/201891,9794,684N/A8,555N/A
12/31/201788,9203,693N/A10,115N/A
9/30/201783,0926,568N/A9,699N/A
6/30/201780,8174,644N/A19,233N/A
3/31/201777,2855,672N/A22,227N/A
12/31/201673,6947,123N/A16,557N/A
9/30/201670,5192,827N/A6,916N/A
6/30/201667,9736,367N/A705N/A
3/31/201665,9036,289N/A-607N/A
12/31/201565,1376,774N/A-3,122N/A
9/30/201563,8349,204N/A6,752N/A
6/30/201563,5388,620N/A9,213N/A
3/31/201563,8078,412N/A12,028N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A096530 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3%).

Earnings vs Market: A096530 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: A096530 is expected to become profitable in the next 3 years.

Revenue vs Market: A096530's revenue (13% per year) is forecast to grow faster than the KR market (11.8% per year).

High Growth Revenue: A096530's revenue (13% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A096530's Return on Equity is forecast to be low in 3 years time (8.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/08 09:06
End of Day Share Price 2026/01/08 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Seegene, Inc. is covered by 17 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David LeeCLSA
Jonghyun ParkDAOL Investment & Securities Co., Ltd.
Jinhee KwakEugene Investment & Securities Co Ltd.